Skip to content

Comparative study on the effect of different drugs on relieving discomfort caused by Lugo's iodine staining in esophagus

Comparative study on the effect of different drugs on relieving discomfort caused by Lugo's iodine staining in esophagus

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070042
Enrollment
Unknown
Registered
2023-03-31
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early esophageal neoplasms and precancerous lesions

Interventions

control group:normal saline
experimental group:N-acetylcysteine solution
experimental group:Vitamin C solution

Sponsors

Shihezi University First Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Those over 40 years of age who meet any of the following criteria: long-term resident in an area with a high incidence of esophageal cancer; A family history of esophageal tumors; Having high risk factors for esophageal cancer (smoking, heavy alcohol consumption, squamous cell carcinoma of the head, neck or respiratory tract, preference for high temperature and preserved food, poor oral hygiene, etc.); 2. Endoscopic screening for suspected esophageal lesions; 3. Patients requiring monitoring after endoscopic resection or radiotherapy for esophageal squamous cell carcinoma.

Exclusion criteria

Exclusion criteria: 1. Allergic to iodine, n-acetylcysteine, vitamin C or hyperthyroidism; 2. Advanced esophageal cancer, esophageal varices, esophageal ulcers, or other conditions that are not suitable for Lugol iodine endoscopy; 3. Severe GERD or reflux symptoms may affect the outcome indicators of the current study; 4. Postoperative esophageal stenosis affected endoscopic observation; 5. Can not cooperate with observation, including mental disorders, serious cardiopulmonary diseases, etc.

Design outcomes

Primary

MeasureTime frame
visual analogue scale;

Secondary

MeasureTime frame
Heart rate changes at time points before and after staining endoscopy;Endoscopic resolution improvement;

Countries

China

Contacts

Public ContactTian Shuxin; Li Chenlu

Shihezi University First Affiliated Hospital

57469085@qq.com+86 17309930036; +86 18899531998

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026